Patents by Inventor Bernhard Hassel

Bernhard Hassel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Highly concentrated stable meloxicam solutions for needleless injection
    Patent number: 10098891
    Abstract: A method for treating pain, inflammation, fever and respiratory complaints in mammals comprising administering by needleless injection to a mammal in need of such treatment an aqueous cyclodextrin-free solution of meloxicam containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: October 16, 2018
    Assignee: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly concentrated stable meloxicam solutions for needleless injection
    Patent number: 9993485
    Abstract: An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: June 12, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly concentrated stable meloxicam solutions
    Patent number: 9993557
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: June 12, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Jurgen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • Highly concentrated stable meloxicam solutions
    Patent number: 9956288
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The solution is for treating a mammal suffering from one or more of pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: May 1, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • PHARMACEUTICAL COMPOSITION INCLUDING PIMOBENDAN
    Publication number: 20170368062
    Abstract: A solid formulation includes pimobendan or a pharmaceutically acceptable salt thereof, which is homogenously dispersed with a polyvalent acid and a flavor suitable to animals.
    Type: Application
    Filed: September 5, 2017
    Publication date: December 28, 2017
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Lehmann
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS
    Publication number: 20170035885
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The solution is for treating a mammal suffering from one or more of pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
    Publication number: 20150051198
    Abstract: An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 19, 2015
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly concentrated stable meloxicam solutions for needleless injection
    Patent number: 8920820
    Abstract: An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: December 30, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • PHARMACEUTICAL COMPOSITION INCLUDING PIMOBENDAN
    Publication number: 20140363510
    Abstract: A solid formulation includes pimobendan or a pharmaceutically acceptable salt thereof, which is homogenously dispersed with a polyvalent acid and a flavor suitable to animals.
    Type: Application
    Filed: August 21, 2014
    Publication date: December 11, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Lehmann
  • Packaging assembly for pharmaceutical composition including pimobendan
    Patent number: 8859554
    Abstract: A packaging assembly or kit includes packaging material containing a solid formulation including pimobendan dispersed in a polyvalent acid. The kit may also include a package leaflet or user instruction including the information concerning use of the solid formulation, for example, via the oral route for the prevention and/or treatment of congestive heart failure in a mammal in need of such prevention or treatment, preferably in a dog, cat or rodent.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: October 14, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Lehmann
  • Pharmaceutical composition comprising pimobendan
    Patent number: 8846679
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound pimobendan and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of congestive heart failure, wherein the solid formulations according to the invention are used.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: September 30, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Schmalz
  • Pharmaceutical composition comprising pimobendan
    Patent number: 8846680
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound pimobendan and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of congestive heart failure, wherein the solid formulations according to the invention are used.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: September 30, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Schmalz
  • Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
    Publication number: 20140113893
    Abstract: An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients.
    Type: Application
    Filed: November 13, 2013
    Publication date: April 24, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
    Publication number: 20140066440
    Abstract: A method for treating pain, inflammation, fever and respiratory complaints in mammals comprising administering by needleless injection to a mammal in need of such treatment an aqueous cyclodextrin-free solution of meloxicam containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 6, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • PACKAGING ASSEMBLY FOR PHARMACEUTICAL COMPOSITION INCLUDING PIMOBENDAN
    Publication number: 20130177613
    Abstract: A packaging assembly or kit includes packaging material containing a solid formulation including pimobendan dispersed in a polyvalent acid. The kit may also include a package leaflet or user instruction including the information concerning use of the solid formulation, for example, via the oral route for the prevention and/or treatment of congestive heart failure in a mammal in need of such prevention or treatment, preferably in a dog, cat or rodent.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 11, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Lehmann (nee Schmalz)
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS
    Publication number: 20130178467
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 11, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • Pharmaceutical Composition Comprising Pimobendan
    Publication number: 20120148640
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound pimobendan and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of congestive heart failure, wherein the solid formulations according to the invention are used.
    Type: Application
    Filed: February 22, 2012
    Publication date: June 14, 2012
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Martin A. Folger, Bernhard Hassel, Stefan Henke, Jens Schmalz
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS FOR NEEDLELESS INJECTION
    Publication number: 20080132493
    Abstract: Aqueous cyclodextrin-free solution of meloxicam suitable for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being from 35 to 100 mg/ml. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: August 27, 2007
    Publication date: June 5, 2008
    Inventors: Martin Andreas Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Highly concentrated stable meloxicam solutions
    Publication number: 20060079516
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: November 30, 2005
    Publication date: April 13, 2006
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin Folger, Klaus Daneck, Axel Prox
  • Liquid composition for veterinary medicine and process for the preparation and use thereof
    Publication number: 20050277634
    Abstract: A liquid composition comprising: meloxicam, penethamate hydroiodide, and at least one solvent.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 15, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Dietrich Janott, Stefan Henke, Martin Folger, Peter Riechel, Bernhard Hassel